Yoshihara Satoshi Department
Specialty Division
, Clinical Medicine Seminars
Position
■ Journal
1.
Original article
Unmanipulated HaploidenticalReduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan. 2015/08
2.
Original article
Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation. 2015/10
3.
Original article
Host Foxp3+CD4+ Regulatory T Cells Act as a Negative regulator of dendritic cells in the peritransplantation period. Journal of Immunology. 2016/01
4.
Original article
Update on granulocyte transfusions: accumulation of promising data, but still lack of decisive evidence. 2016/01
A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning. 2018/04
7.
Original article
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment. 2018/05
8.
Original article
Aldehyde dehydrogenase activity in cryopreserved cord blood cells for quality assessment prior to transplantation. 2018/11
9.
Original article
Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation. 2019/06
10.
Original article
Early evaluation of tumor response to90 2019/07
11.
Original article
Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. 2019/07
12.
Original article
Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP. 2019/09
13.
Original article
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospectiv phaseⅠ/Ⅱ study 2020/06
14.
Original article
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion 2020/06
15.
Research report
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis 2021/04
16.
Original article
Expression of activated integrin β7 in multiple myeloma patients 2021/07
17.
Original article
High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy 2021/09
18.
Original article
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia 2021/10
19.
Case report
Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma 2021/12
20.
Original article
Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis 2022/01
21.
Original article
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain 2022/02
22.
Case report
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone 2022/02
clinical outcomes of HLA haploidentical hematopoietic stem cell transplantation in patients with Philadelphia Chromosome positive Acute Lymphoblastic Leukemia in our institute (Oral presentation,General Lecture) 2016/03/04
2.
Cryopreservation of autologous blood from an Rhmod patient in cooperation with Hyogo Blood Center. (Poster presentation,General Lecture) 2016/08
3.
Clinical Application of human aminon-derived mesenchymal stem cells to treat acute GVHD (Poster presentation,General Lecture) 2017/03/02
4.
Study on citrate intozication during peripheral blood stem cell harvesting (Poster presentation,General Lecture) 2017/03/02
5.
Association beteween plasma concentration of antithymocyte globulin(ATG) and acute graft versus host disease(GVHD) granding on haploidentical hematopoietic stem cell transplantation (Oral presentation,General Lecture) 2017/03/04
Lymphocyte apheresis and cell processing for CAR-T cell therapy"Kymriah" using the existing facility in the blood transfusion department (Oral presentation,General Lecture) 2020/03/06
17.
Phamacokinetics of cidofovir in Japanese patients receiving hematopoietic stem cell transplantation (Oral presentation,General Lecture) 2020/03/06
18.
Decision making in AYA patients with hematological malignancy underwent HLA mismatch transplants. (Web announcement,General Lecture) 2021/03
19.
Survival-time analysis using recurrent neural networks in hematopoietic stem cell transplantation (Web announcement,General Lecture) 2021/03
20.
Tisagenlecleucel for Diffuse Large B-cell Lymphoma:A Single Center Experience (Web announcement,General Lecture) 2021/03
21.
Two cases of incidental plasma cell neoplasm: diagnostic roles of EMA and CD79a immunohistochemistry (Poster presentation) 2021/09/23
22.
A case of cutaneous infiltration of CD8-positive atypical T-cells with monoclonal integration of HTLV-1 (Poster presentation,General Lecture) 2022/06/23